Xarelto (zah-rel-toe) is the latest ORAL anticoagulant to hit the Canadian market

Xarelto (zah-rel-toe) is the latest ORAL anticoagulant to hit the Canadian market...just a few months after Pradax.

Both will be used as alternatives to low-molecular-weight heparin (Lovenox, etc)...to prevent clots after knee or hip replacement.

Patients will take Xarelto 10 mg orally once daily...for 14 days after a knee replacement or 35 days after a hip replacement.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote